Expression of tumour necrosis factor‐α in cryptogenic fibrosing alveolitis

Histopathology

Volumn 22, Issue 4, 1993, Pages 343-347

  NASH, J R G ^a   MCLAUGHLIN, P J ^a   BUTCHER, D ^b   CORRIN, B ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

bronchial epithelium; cryptogenic fibrosing alveolitis; macrophage; pulmonary fibrosis; tumour necrosis factor ; type II pneumocyte

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS CELL TYPE 2; LUNG FIBROSIS; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; EPITHELIUM; HUMAN; IMMUNOENZYME TECHNIQUES; MACROPHAGES, ALVEOLAR; PULMONARY FIBROSIS; TUMOR NECROSIS FACTOR;

EID: 0027231698     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.1993.tb00133.x     Document Type: Article

References (42)

1. Cachectic effects of recombinant human tumour necrosis factor in rats
2. Detection of tumour necrosis factor/cachectin in pleural fluid of patients with lung cancer
3. Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration
4. Role of tumor necrosis factor in sepsis and acute lung injury
5. Tumour necrosis factor: receptor binding and mitogenic action in fibroblasts
6. Regulation of human lung fibroblast collagen production by recombinant interleukin‐1, tumor necrosis factor, and interferon‐gamma
7. Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis
8. Accuracy of diagnostic coding of hospital admissions for cryptogenic fibrosing alveolitis
9. Interstitial lung disease of unknown aetiology
10. Some connective tissue disorders of the lung
11. Structural features of interstitial lung disease in systemic sclerosis
12. The ultrastructure of human fibrosing alveolitis
13. Diffuse alveolar damage
14. Relationship of interstitial pneumonia honeycombing and atypical epithelial proliferation to cancer of the lung
15. Idiopathic diffuse interstitial pulmonary fibrosis (fibrosing alveolitis). atypical epithelial proliferation and lung cancer
16. Carcinoma and diffuse interstitial fibrosis of the lung
17. Cryptogenic fibrosing alveolitis and lung cancer
18. Diffuse interstitial pulmonary fibrosis and lung cancer
19. Immunolocalization of tumour necrosis factor‐alpha in lung tissue from patients dying with adult respiratory distress syndrome
20. Properties of monoclonal antibodies to human tumor necrosis factor alpha (TNFalpha)
21. Cryptogenic fibrosing alveolitis: assessment by graded trephine lung biopsy histology compared with clinical, radiographic, and physiological features
22. Tumour necrosis factor alpha‐induced pulmonary vascular endothelial injury
23. Tumor necrosis factor causes increased pulmonary permeability and edema
24. Tumour necrosis factor‐alpha augments pulmonary arterial transendothelial albumin flux in vitro.
25. Renewal of alveolar epithelium in the rat following exposure to NO2
26. The type 2 cells as progenitor of alveolar epithelial regeneration
27. Transformation of alveolar type 2 cells to type 1 cells following exposure to NO2
28. Pathogenesis of ‘librosis’ in interstitial pneumonia: an electron microscopic study
29. Pathogenesis of pulmonary fibrosis
30. Acute interstitial pneumonia. A clinicopathologic, ultrastructural, and cell kinetic study
31. Pulmonary perspective. Alveolitis and collapse in the pathogenesis of pulmonary fibrosis
32. The TH. Expression of class II major histocompatibility complex antigens on alveolar epithelium in interstitial lung disease: relevance to pathogenesis of idiopathic pulmonary fibrosis
33. Phenotypic characterization of alveolar capillary endothelial cells, alveolar epithelial cells and alveolar macrophages in patients with pulmonary fibrosis with special reference to MHC class II antigens
34. The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage
35. Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimens
36. Pulmonary fibrosis–a possible mechanism
37. Diffuse interstitial pulmonary fibrosis. Pulmonary fibrosis in mice induced by treatment with butylated hydroxytoluene and oxygen
38. Epithelial cell‐fibroblast interactions in lung injury and repair
39. Repeated exposures to enzyme‐generated oxidants cause alveolitis, epithelial hyper‐plasia, and fibrosis in hamsters
40. Intestitial associations of cells lining air spaces in human pulmonary fibrosis
41. Epithelial‐mesenchymal associations of cells in human pulmonary fibrosis and in BHT‐oxygen‐induced fibrosis in mice
42. Repopulation of denuded tracheal grafts with normal, preneoplastic and neoplastic epithelial cell populations